A sound investment process and strong management team underpin BlackRock Health Sciences Opps Svc's Morningstar Quantitative Rating of Bronze. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
- NAV / 1-Day Return 65.20 / 0.73 %
- Total Assets 9.0 Bil
Adj. Expense Ratio
- Expense Ratio 1.140%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 5,000
- Status Open
- TTM Yield 0.27%
- Turnover 51%
Morningstar’s Analysis SHISX
Will SHISX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.